Description
RAPGLYVOR-2 contains Voglibose, Glimepiride and Metformin Hydrochloride Tablets. This combination is used to help manage blood glucose levels in adults with Type 2 Diabetes Mellitus when prescribed by a qualified healthcare professional.
The three medicines work through different actions. Voglibose helps slow the digestion and absorption of carbohydrates. Glimepiride helps the pancreas release insulin. Metformin helps reduce glucose production in the liver and improves the body’s response to insulin.
Brand Name: RAPGLYVOR-2
Composition: Voglibose + Glimepiride + Metformin Hydrochloride Tablets
Dosage Form: Tablets
Therapeutic Category: Antidiabetic Medicine
Indication: Type 2 Diabetes Mellitus
Company: Rapid Life Drugs & Healthcare
Voglibose + Glimepiride + Metformin Hydrochloride Tablets
Voglibose + Glimepiride + Metformin Hydrochloride Tablets combine three antidiabetic medicines in one formulation. Doctors may prescribe this combination when diet, exercise and other diabetes treatments do not provide adequate blood glucose control.
Voglibose belongs to the alpha-glucosidase inhibitor class. It delays carbohydrate digestion in the intestine and helps reduce the rise in blood glucose after meals.
Glimepiride belongs to the sulfonylurea class. It stimulates the pancreas to release insulin.
Metformin belongs to the biguanide class. It mainly reduces glucose production by the liver and improves insulin sensitivity.
Together, these medicines provide complementary actions for blood sugar management.
Uses of RAPGLYVOR-2
Doctors may prescribe RAPGLYVOR-2 to:
- Manage Type 2 Diabetes Mellitus
- Improve blood glucose control
- Help control blood sugar after meals
- Support diabetes treatment with diet and exercise
- Provide combination therapy for patients who need multiple antidiabetic medicines
However, this combination is not a standard treatment for Type 1 Diabetes Mellitus or diabetic ketoacidosis.
How Does RAPGLYVOR-2 Work?
Voglibose
Voglibose slows the breakdown of carbohydrates in the intestine. As a result, glucose enters the bloodstream more slowly after meals. This action can help reduce post-meal blood glucose levels.
Glimepiride
Glimepiride stimulates the pancreas to release insulin. The increased insulin helps the body lower elevated blood glucose levels.
Metformin Hydrochloride
Metformin reduces glucose production by the liver. It also improves the body’s response to insulin. Therefore, the body can use glucose more effectively.
Benefits of Voglibose + Glimepiride + Metformin Tablets
RAPGLYVOR-2 provides three complementary actions for blood glucose management:
- Helps support overall blood sugar control
- Helps manage post-meal blood glucose levels
- Combines three antidiabetic medicines in one formulation
- Supports Type 2 Diabetes management
- Can complement a healthy diet and regular physical activity
- Provides convenient combination therapy when prescribed
Dosage and Administration
Take RAPGLYVOR-2 only as prescribed by your doctor. The appropriate dose depends on your blood glucose levels, medical history, kidney function and response to treatment.
Follow the prescribed schedule and take the medicine as directed. Do not change the dose or stop treatment without medical advice.
Voglibose is commonly taken before meals when prescribed in this type of combination. Follow the specific instructions provided by your doctor and the product packaging.
Possible Side Effects
Some patients may experience side effects while taking Voglibose, Glimepiride and Metformin. These may include:
- Gas
- Abdominal discomfort
- Diarrhea
- Nausea
- Loss of appetite
- Headache
- Dizziness
- Low blood sugar
Side effects can vary between patients. Contact your doctor if any side effect becomes severe or continues for a long time.
Precautions
Before starting RAPGLYVOR-2, tell your doctor about your medical history. Also, share details of all medicines and supplements you currently take.
Your doctor may need to monitor you carefully if you have:
- Kidney problems
- Liver problems
- A history of low blood sugar
- Digestive or intestinal disorders
- Excessive alcohol use
- Conditions that may cause dehydration
Glimepiride can cause low blood sugar. Therefore, learn to recognize symptoms such as sweating, shaking, hunger, dizziness and confusion.
Metformin can rarely cause lactic acidosis. The risk can increase in people with severe kidney problems or certain other medical conditions.
Why Choose RAPGLYVOR-2 from Rapid Life Drugs & Healthcare?
Rapid Life Drugs & Healthcare offers pharmaceutical products across different therapeutic categories. RAPGLYVOR-2 – Voglibose + Glimepiride + Metformin Hydrochloride Tablets is part of its antidiabetic product portfolio.
The formulation combines three different mechanisms to support blood glucose management in suitable patients with Type 2 Diabetes Mellitus.
For product information, availability and pharmaceutical business enquiries, contact Rapid Life Drugs & Healthcare.
Frequently Asked Questions
What is RAPGLYVOR-2?
RAPGLYVOR-2 is a combination formulation containing Voglibose + Glimepiride + Metformin Hydrochloride Tablets. Doctors may prescribe it to manage Type 2 Diabetes Mellitus.
What is the composition of RAPGLYVOR-2?
RAPGLYVOR-2 contains Voglibose, Glimepiride and Metformin Hydrochloride. Please confirm the exact strengths from the approved product specification and packaging.
What is Voglibose + Glimepiride + Metformin used for?
Doctors may use this combination to help control blood glucose levels in adults with Type 2 Diabetes Mellitus.
How does Voglibose work?
Voglibose slows carbohydrate digestion and glucose absorption in the intestine. This can help reduce the rise in blood glucose after meals.
How does Glimepiride work?
Glimepiride stimulates the pancreas to release insulin. This helps lower elevated blood glucose levels.
How does Metformin work?
Metformin reduces glucose production by the liver. It also improves the body’s response to insulin.
Is RAPGLYVOR-2 a prescription medicine?
Yes. Use RAPGLYVOR-2 only under the guidance of a qualified healthcare professional.
Can RAPGLYVOR-2 be used for Type 1 Diabetes?
This combination is generally intended for Type 2 Diabetes Mellitus. It is not a standard treatment for Type 1 Diabetes.
About Rapid Life Drugs & Healthcare
Rapid Life Drugs & Healthcare is a pharmaceutical company offering products across different therapeutic segments. Its portfolio includes formulations for diabetes and other healthcare requirements.
The company offers RAPGLYVOR-2 – Voglibose + Glimepiride + Metformin Hydrochloride Tablets as part of its antidiabetic product range.
For product enquiries and pharmaceutical business opportunities, contact Rapid Life Drugs & Healthcare.
